Small-Cap Winners & Losers: Innophos Holdings
Small-cap stocks were taking on modest gains contrary to the broader markets early Friday. The Russell 2000 was tacking on 0.16% to 715.12 while the S&P SmallCap 600 was gaining 0.11% at 372.53.
Seeing positive gains early Friday was Innophos Holdings (IPHS), moving up 30.75% to $38.40. The Cranbury, N.J.-based producer of specialty phosphates in North America was upgraded by Standard & Poor's rating services to a B+ from a B. S&P said that its outlook is positive.
Slumping in early trading was TomoTherapy (TOMO), falling 46% to $5.26. The Madison, Wis.-based marketer of a radiation therapy system was downgraded by Robert W. Baird and Piper Jaffray to neutral from outperform and to neutral from buy, respectfully. TomoTherapy said it was removing $53 million in orders from its backlog.
Reporting a strong quarter, aerospace goods manufacturer Astronics (ATRO) was adding 36.2% to $19.89 Friday. The East Aurora, N.Y.-based firm reported net income growing to $5.1 million from $4.5 million year over year. On a per share basis, the company said net income increased to 60 cents from 53 cents year over year.
Union Drilling (UDRL) was falling a significant 15.6% to $16.22. The Fort Worth, Texas-based land driller reported poor second quarter results with net income down to $3.4 million from $9.2 million; a 63% decline year over year. Revenue rose a dismal 2% to $75.5 million from $74.2 million in the prior-year's second quarter. comScore (SCOR) was raking in massive gains, shooting up 16.7% to $22.17. The Reston, Va.-based digital platform provider reported an increase in net income to $1.7 million from $317,000 a year earlier and a significant improvement of 38% in revenue to $24.3 million. A year earlier, the business services company was at break even per share.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV